Study explores the science behind cannabis-based medicinal products in pediatric epilepsies

Learn anything. Thousands of top courses to choose from.
Children

Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products.

A review published in Developmental Medicine & Child Neurology explores the science behind cannabis-based medicinal products in pediatric epilepsies and highlights areas that warrant additional research.

The authors also examined the prescribing environment surrounding these products. They found that a lack of quality evidence for efficacy and safety is the major obstacle to prescribing

Journal reference:

Kirkpatrick, M & O’ Callaghan, F., (2021) Epilepsy and cannabis: so near, yet so far. Developmental Medicine & Child Neurology. doi.org/10.1111/dmcn.15032.

Articles You May Like

Food Insecurity Contributes to HF Mortality in Populations
Guidelines: Summer camp returns to normal during COVID-19
Nurse Glitzes Up Gloomy Times With Vaccine Chandelier
TikTok and TOWIE announce new measures to protect mental health
Obesity Cases On The Rise Amid COVID-19 Pandemic

Leave a Reply

Your email address will not be published. Required fields are marked *